Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACC's 57th Annual Scientific Session

    SAN DIEGO, March 26 /PRNewswire/ -- Eric J. Topol, M.D., chief academic
 officer of Scripps Health and director of the Scripps Translational Science
 Institute, will present a late-breaking lecture about advancements in the
 genomics of cardiovascular disease at the American College of Cardiology's
 (ACC) 57th Annual Scientific Session in Chicago.
 
     Dr. Topol's presentation on March 31 will include data concerning new,
 compelling genomic markers for myocardial infarction, coronary artery
 disease, atrial fibrillation and abnormal lipoproteins. A panel discussion
 about the progress, limitations, caveats and future issues in
 cardiovascular genomic medicine will follow the presentation.
 
 

     Who:     Eric J. Topol, M.D., Chief Academic Officer, Scripps Health;
              Director of Scripps Translational Science Institute; Professor of
              Translational Genomics, The Scripps Research Institute
 
     What:    Late-breaking lecture about advancements in the genomics of
              cardiovascular disease
 
     When:    3:30 p.m.-4:30 p.m. CDT, March 31
 
     Where:   North Hall B1, McCormick Place, Chicago
 
     About Scripps Genomic Medicine
 
     An initiative of Scripps Health and The Scripps Research Institute,
 Scripps Genomic Medicine is an innovative program in which genomic
 researchers, clinicians and other specialists are working side-by-side to
 advance medicine. Current projects include the genotyping of tens of
 thousands of individuals of diverse ancestry to identify and define genes
 that are responsible for major disease and the underpinnings of health.
 Through The Scripps Translational Science Institute, this basic research
 will be translated into drug discovery programs and, ultimately, clinical
 trials. These trials, launched through Scripps Advanced Clinical Trials,
 will test individualized treatment and prevention strategies in
 collaboration with pharmaceutical, medical device, biotechnology and
 diagnostic companies. For more information, visit
 http://www.scrippshealth.org/genomic.
 
     About Scripps Health
 
     Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps
 Health is a non-profit community health system based in San Diego. Scripps
 treats a half-million patients annually through the dedication of 2,600
 affiliated physicians and 11,000 employees among its five acute-care
 hospital campuses, home health care services, and an ambulatory care
 network of clinics, physician offices and outpatient centers. Recognized as
 a national leader in the prevention, diagnosis, and treatment of disease,
 Scripps is also at the forefront of clinical research and graduate medical
 education. For more information, visit http://www.scrippshealth.org.
 
 
 

SOURCE Scripps Health